Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
40.56
+1.37 (3.50%)
At close: Feb 18, 2026, 4:00 PM EST
40.56
0.00 (0.00%)
After-hours: Feb 18, 2026, 7:00 PM EST

Hinge Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
587.86390.4292.73
Revenue Growth (YoY)
50.58%33.37%-
Cost of Revenue
118.5689.8198.55
Gross Profit
469.3300.59194.18
Selling, General & Admin
639.41227.54214.64
Research & Development
354.397.49110.06
Other Operating Expenses
16.61--
Operating Expenses
1,010325.02324.69
Operating Income
-541.02-24.43-130.51
Interest & Investment Income
-20.5721.7
Other Non Operating Income (Expenses)
19.110.080.27
EBT Excluding Unusual Items
-521.91-3.78-108.55
Merger & Restructuring Charges
-5.35-7.48-
Pretax Income
-527.26-11.26-108.55
Income Tax Expense
10.68-0.41
Net Income
-528.26-11.93-108.14
Preferred Dividends & Other Adjustments
-104.17--
Net Income to Common
-424.09-11.93-108.14
Shares Outstanding (Basic)
551413
Shares Outstanding (Diluted)
551413
Shares Change (YoY)
302.55%4.16%-
EPS (Basic)
-7.77-0.88-8.31
EPS (Diluted)
-7.77-0.88-8.31
Free Cash Flow
170.7347.96-65.89
Free Cash Flow Per Share
3.133.54-5.06
Gross Margin
79.83%77.00%66.33%
Operating Margin
-92.03%-6.26%-44.59%
Profit Margin
-72.14%-3.06%-36.94%
Free Cash Flow Margin
29.04%12.29%-22.51%
EBITDA
-535.89-22.08-128.39
EBITDA Margin
-91.16%-5.66%-43.86%
D&A For EBITDA
5.132.352.13
EBIT
-541.02-24.43-130.51
EBIT Margin
-92.03%-6.26%-44.59%
Advertising Expenses
-37.323.8
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q